Literature DB >> 28390566

Vasculitis and Pregnancy.

Leah Machen1, Megan E B Clowse2.   

Abstract

Vasculitis is more often a disease of women beyond their reproductive years, leaving the challenges of pregnancy management difficult to study. Pregnancy complications, including pregnancy loss and preterm birth, are higher among women with all forms of vasculitis. It seems that controlling the disease before pregnancy may improve the chances of pregnancy success. Many medications used for vasculitis are considered low risk in pregnancy, including prednisone, colchicine, azathioprine, and tumor necrosis factor inhibitors. Cyclophosphamide, methotrexate, and mycophenolate mofetil should be avoided in pregnancy. Controlling disease with low-risk medications may allow women with vasculitis to have the pregnancies they desire.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ANCA-associated vasculitis; Behçet disease; Prednisone; Pregnancy; TNF-Inhibitor; Takayasu arteritis; Vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28390566     DOI: 10.1016/j.rdc.2016.12.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  6 in total

Review 1.  Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.

Authors:  Ann-Christin Pecher; Melanie Henes; Joerg Christoph Henes
Journal:  Arch Gynecol Obstet       Date:  2022-09-14       Impact factor: 2.493

Review 2.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 3.  Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

Authors:  Catherine King; Lorraine Harper
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-11-13

Review 4.  Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases.

Authors:  Silvia Cavalli; Paola Adele Lonati; Maria Gerosa; Roberto Caporali; Rolando Cimaz; Cecilia Beatrice Chighizola
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

Review 5.  A comprehensive guide for managing the reproductive health of patients with vasculitis.

Authors:  Catherine Sims; Megan E B Clowse
Journal:  Nat Rev Rheumatol       Date:  2022-10-03       Impact factor: 32.286

Review 6.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.